Annual General Meeting 2017 in ChromoGenics AB (publ)
ChromoGenics AB (publ) held its Annual General Meeting May 10th 2017 in Uppsala.Annual Report and Results The Annual General Meeting adopted the profit and loss statement and the balance sheet for the financial year 2016 and decided, in accordance with the Board's proposal, that the accumulated loss of a total of SEK 38,902,527 was carried forward in new account. It was further resolved that no dividend was to be paid. Discharge The Annual General Meeting discharged the Board members and the Managing Director from liability for the financial year 2016. Board and auditor's fees